Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Owlstone Medical

publication date: Sep 12, 2017
 | 
author/source: Owlstone Medical

Recognizes potential of the breath biopsy platform to transform diagnostics - ReCIVA Breath Sampler will be on display from Friday August 18th, 2017

owlstoneOwlstone Medical, a diagnostics company, has announced that its disease breathalyzer, ReCIVA™ has been selected to feature in the Tomorrow’s World gallery at the Science Museum, London. The exhibition aims to inspire visitors with award-winning, cutting-edge scientific advances such as advanced surgical robotics, space suits and avalanche analysis technology. ReCIVA was selected to feature based on its potential to revolutionize healthcare and bring real benefits to patients, and will be on display from Friday August 18th, 2017.

Owlstone Medical’s CE-marked ReCIVA Breath Sampler forms part of the Company’s Breath Biopsy® platform, which analyzes biomarkers from breath to diagnose disease. ReCIVA is used to collect samples of breath from a patient, completely non-invasively, and analyze them with high sensitivity and selectivity.

Each exhaled breath contains a rich spectrum of Volatile Organic Compounds (VOCs) produced by the body’s metabolism that relate directly to disease activity. When analyzed, this information can enable early diagnosis and provide important insights for patient stratification, helping to ensure that the right therapy is given to the right patient at the right time, to improve clinical outcomes and reduce healthcare costs.

Billy Boyle, co-founder and CEO at Owlstone Medical commented: “Our Breath Biopsy platform presents a new approach to detect disease earlier and make better treatment decisions for patients. The ReCIVA Breath Sampler is a reliable and reproducible way to capture VOC biomarkers in breath samples, which can be sent to Owlstone Medical’s clinical laboratory in Cambridge for analysis. The technology is already in use in over 60 research and clinical labs globally, and we are honored that it has been selected to feature in the Science Museum’s Tomorrow’s World gallery.”


more about owlstone




 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events